ArticleWorld journal of gastrointestinal endoscopy2022
Texture and color enhancement imaging in magnifying endoscopic evaluation of colorectal adenomas.
Article in World journal of gastrointestinal endoscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 19 citations in OpenAlex.
- Efficacy of image-enhanced endoscopy for colorectal polyp detection.Clinical endoscopy · 2026Review
- Review
- Article
- Visibility of esophageal squamous cell carcinoma under iodine staining on texture and color enhancement imaging.DEN open · 2025Article
- Red dichromatic imaging enhances submucosal visibility during endoscopic submucosal dissection: Pilot study.Endoscopy international open · 2025Article
- Endoscopic characteristics to differentiate SSLs and microvesicular hyperplastic polyps from goblet cell-rich hyperplastic polyps.Endoscopy international open · 2024Article
- Effect of texture and color enhancement imaging on the visibility of gastric tumors.Scientific reports · 2024Article
- Topic highlight on texture and color enhancement imaging in gastrointestinal diseases.World journal of gastroenterology · 2024Article
- Improved visibility of colorectal tumor by texture and color enhancement imaging with indigo carmine.World journal of gastrointestinal endoscopy · 2023Article
- Hemorrhoids as a risk factor for colorectal adenomas on colonoscopy.Endoscopy international open · 2023Article
- Using texture and colour enhancement imaging to evaluate gastrointestinal diseases in clinical practice: a review.Annals of medicine · 2022Review
- Texture and color enhancement imaging for detecting colorectal adenomas: Good, but not good enough.World journal of gastrointestinal endoscopy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOlympus Corporation has developed texture and color enhancement imaging (TXI) as a novel image-enhancing endoscopic technique.
aimTo investigate the effectiveness of TXI in identifying colorectal adenomas using magnifying observation.
methodsColorectal adenomas were observed by magnified endoscopy using white light imaging (WLI), TXI, narrow band imaging (NBI), and chromoendoscopy (CE). This study adopted mode 1 of TXI. Adenomas were confirmed by histological examination. TXI visibility was compared with the visibility of WLI, NBI, and CE for tumor margin, and vessel and surface patterns of the Japan NBI expert team (JNET) classification. Three expert endoscopists and three non-expert endoscopists evaluated the visibility scores, which were classified as 1, 2, 3, and 4.
resultsSixty-one consecutive adenomas were evaluated. The visibility score for tumor margin of TXI (3.47 ± 0.79) was significantly higher than that of WLI (2.86 ± 1.02,
conclusionTXI provided higher visibility than WLI, lower than NBI, and comparable to or higher than CE in the magnified observation of colorectal adenomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.